Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by BaytexBullon Sep 06, 2016 7:15am
237 Views
Post# 25209073

Analyst Review

Analyst Review
SELL Christine Poole

Has never owned this. This company grows by acquisition. They’ve had some problems in the past quarter when they cut their guidance going forward, and had to write down the value of some of their drugs. They also have a big debt load. There is poor visibility on their earnings. The CFO is leaving and there is an interim CFO stepping in. There is a lot of confusion as to what the company is going to look like going forward. If you own, she would recommend you cut your loss.

 Price:
$11.940
Subject:
NORTH AMERICAN - LARGE
Bias:
OPTIMISTIC
Owned:
No
       

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities